Compare RGNX & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGNX | USCB |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 418.1M |
| IPO Year | 2015 | 2021 |
| Metric | RGNX | USCB |
|---|---|---|
| Price | $7.26 | $19.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | $21.40 | ★ $23.25 |
| AVG Volume (30 Days) | ★ 1.1M | 90.4K |
| Earning Date | 11-05-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 2.54% |
| EPS Growth | ★ 18.08 | 7.26 |
| EPS | N/A | ★ 1.51 |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | N/A | $20.71 |
| Revenue Next Year | $24.01 | $7.63 |
| P/E Ratio | ★ N/A | $13.02 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $17.49 |
| 52 Week High | $16.19 | $23.89 |
| Indicator | RGNX | USCB |
|---|---|---|
| Relative Strength Index (RSI) | 44.73 | 34.08 |
| Support Level | $6.79 | $19.15 |
| Resistance Level | $7.32 | $20.10 |
| Average True Range (ATR) | 0.59 | 0.49 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 15.40 | 7.96 |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.